Nearly 70 years later: the continued unraveling of Castleman disease

por van Rhee, Frits
Publicado 2022

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives

por Shrivastava, Trilok, Van Rhee, Frits, Al Hadidi, Samer
Publicado 2023

Profile of elotuzumab and its potential in the treatment of multiple myeloma

por Liu, Yi-Chang, Szmania, Susann, van Rhee, Frits
Publicado 2014

Acquired hemophilia A (AHA) due to anti‐SARS‐CoV‐2 vaccination: A systematic review

por Amisha, Fnu, Saluja, Prachi, Malik, Paras, Van Rhee, Frits
Publicado 2023

Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report

por Lang, Evan, Sande, Brenda, Brodkin, Samantha, van Rhee, Frits
Publicado 2022

Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients

por Roy Choudhury, Samrat, Ashby, Cody, Zhan, Fenghuang, van Rhee, Frits
Publicado 2021

Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing

por Gralewski, Jonathon H., Post, Ginell R., van Rhee, Frits, Yuan, Youzhong
Publicado 2018

Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malign...

por Al Hadidi, Samer, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, van Rhee, Frits
Publicado 2022

Safety and Tolerability of Sars-Cov-2 Vaccination and Natural History of Infection Among Patients with Castleman Disease

por Pierson, Sheila K, Perkins, Russell, van Rhee, Frits, Casper, Corey, Fajgenbaum, David C
Publicado 2021

Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis

por Nishimura, Yoshito, Nishimura, Midori Filiz, Fajgenbaum, David C., van Rhee, Frits, Sato, Yasuharu, Otsuka, Fumio
Publicado 2022

Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States

por Al Hadidi, Samer, Dongarwar, Deepa, Salihu, Hamisu, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, van Rhee, Frits
Publicado 2022

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

por van Rhee, Frits, Rosenthal, Adam, Kanhai, Karan, Martin, Rabecka, Nishimura, Katherine, Hoering, Antje, Fajgenbaum, David C.
Publicado 2022

Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma

por Al Hadidi, Samer, Dongarwar, Deepa, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John D., van Rhee, Frits
Publicado 2023

Expression of integrin β-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics

por Roy Choudhury, Samrat, Byrum, Stephanie D., Alkam, Duah, Ashby, Cody, Zhan, Fenghuang, Tackett, Alan J., Van Rhee, Frits
Publicado 2023

Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma

por Alqazaqi, Raghad, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John, Zhan, Fenghuang, Tricot, Guido, van Rhee, Frits, Al Hadidi, Samer
Publicado 2022

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis

por Mazahreh, Farah, Mazahreh, Liyan, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John D., Zhan, Fenghuang, van Rhee, Frits, Al Hadidi, Samer
Publicado 2023

Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model t...

por Rossi, Jean-Francois, Chiang, Hao-Chun, Lu, Zhao-Yang, Levon, Kalle, van Rhee, Frits, Kanhai, Karan, Fajgenbaum, David C, Klein, Bernard
Publicado 2021

Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling

por Rossi, Jean-François, Chiang, Hao-Chun, Lu, Zhao-Yang, Levon, Kalle, van Rhee, Frits, Kanhai, Karan, Fajgenbaum, David C., Klein, Bernard
Publicado 2022

3195 Genomic Analysis of Primary Plasma Cell Leukemia reveals Complex Cytogenetic Alterations and High Risk Mutational Patterns

por Schinke, Carolina, Boyle, Eileen, Ashby, Cody, Wang, Yan, Christopher Wardell, Davies, Thanendrarajan, Sharmilan, Zangari, maurizio, van Rhee, Frits, Morgan, Gareth, Walker, Brian
Publicado 2019

MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma

por Qiang, Ya-Wei, Ye, Shiqiao, Huang, Yuhua, Chen, Yu, Van Rhee, Frits, Epstein, Joshua, Walker, Brian A., Morgan, Gareth J., Davies, Faith E.
Publicado 2018